The Alzheimer's therapeutic Lecanemab induces an amyloid-clearing program in microglia
Giulia Albertini, Magdalena Zielonka, Cuypers Marie-Lynn, An Snellinx, Ciana Xu, Poovathingal Suresh, Wojno Marta, Kristofer Davie, van Lieshout Veerle, Katleen Craessaerts, Leen Wolfs, Emanuela Pasciuto, Julia Tom, Katrien Horré, Lutgarde Serneels, , Bart De Strooper
This study shows Lecanemab reduces amyloid pathology by activating microglia through Fc fragment engagement, enhancing phagocytosis and lysosomal degradation.
bioRxiv · Jul 24, 2025 · PreprintNeuroscience